Rushing to a higher dose too quickly is a common mistake that leads to overwhelming exhaustion and severe GI issues
Some patients notice early shifts in energy or recovery
Eli Lilly, the manufacturer of Mounjaro and Zepbound, has reported instances where bacteria or high levels of impurities were found in compounded tirzepatide
There's also evidence that GLP-1 agonists, like semaglutide and tirzepatide sold as Mounjaro, Ozempic, Wegovy and Zepound lower the risk of cardiovascular diseases protect the kidney and the liver, reduce inflammation and pain, prevent addiction and substance abuse, help people with arthritis and those with sleep apnea
As anticipated, among those patients who remained on treatment with semaglutide by the EOS, 78.2% and 78.9% of those in the low/no CKD risk cohort and CKD cohort, respectively, were being administered the full dose of 1 mg weekly at that time whereas only one patient remained with the initial dose of 0.25 mg weekly